Team approach: Management of osteonecrosis in children with acute lymphoblastic leukemia.
Lynne C JonesSue C KasteSeth E KarolBrian DeFeoHarry K W KimMichael D NeelAdam S LevinPublished in: Pediatric blood & cancer (2020)
With current treatments for acute lymphoblastic leukemia (ALL), the overall prognosis for survival is favorable. Increasing emphasis is placed on recognizing and managing the long-term consequences of ALL and its treatment, particularly involving osteonecrosis. Early osteonecrosis diagnosis and management may improve outcomes and is best accomplished through coordinated teams that may include hematologic oncologists, radiologists, orthopedic surgeons, physical therapists, and the patient and their family. Magnetic resonance imaging is the "gold standard" for diagnosis of early-stage and/or multifocal osteonecrosis. Treatments for osteonecrosis in ALL patients are risk stratified and may include observation, corticosteroid or chemotherapy adjustment, and pharmaceutical or surgical approaches.
Keyphrases
- acute lymphoblastic leukemia
- early stage
- magnetic resonance imaging
- end stage renal disease
- allogeneic hematopoietic stem cell transplantation
- newly diagnosed
- ejection fraction
- quality improvement
- chronic kidney disease
- computed tomography
- young adults
- prognostic factors
- mental health
- case report
- squamous cell carcinoma
- artificial intelligence
- adipose tissue
- skeletal muscle
- patient reported outcomes
- silver nanoparticles
- neoadjuvant chemotherapy
- smoking cessation
- advanced cancer
- rectal cancer